DUBLIN, March 16, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/n5t3n6/global_monoclonal) has announced the addition of the "Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials" report to their offering.
The Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016: Deal trends, players, financials and forecasts report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
This report provides details of the latest monoclonal antibody agreements announced in the healthcare sectors, covering:
Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016 includes:
In Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016, the available deals are listed by:
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in monoclonal antibody dealmaking
Chapter 3 - Leading monoclonal antibody deals
Chapter 4 - Most active monoclonal antibody dealmakers
Chapter 5 - Monoclonal antibody contracts dealmaking directory
Chapter 6 - Monoclonal antibody dealmaking by technology type
Chapter 7 - Partnering resource center
For more information visit http://www.researchandmarkets.com/research/n5t3n6/global_monoclonal
Media Contact:
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article